Digital CBT-I for Insomnia Disorder (CrEDIT)
Primary Purpose
Insomnia Disorder
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
digital CBT-I
Sleep hygiene education
Sponsored by
About this trial
This is an interventional treatment trial for Insomnia Disorder focused on measuring Insomnia, digital CBT, CBT-I
Eligibility Criteria
Inclusion Criteria:
- Age ≥22 years old
- Insomnia Disorder diagnosis
- Score ≤16 on the 8-item Sleep Condition Indicator
- > 30 minutes sleep onset latency (SOL); and/or > 30 minutes wake after sleep onset (WASO)
- Current resident of the USA
- Oral and written fluency in English
- Participant is able and willing to comply with protocol requirements, has been informed of the nature of the study, and has signed the IRB-approved informed consent form
Exclusion Criteria:
- Must not be currently receiving or be expecting to start CBT for insomnia during study participation, or have previously received CBT for insomnia in the past 12-months (self-report)
- If on psychoactive medication, including sleep medication, this must be stable for at least 5 half lives
- Past or present psychosis, schizophrenia, bipolar disorder, assessed by self-report and/or seizure disorder
- Occupation that requires alertness / caution to avoid accidents, for example long-haul driving, long distance bus driver, heavy machinery operator, air traffic controller
- Hearing or vision impairment that prevents effective use of the audio-visual content of digital CBT-I or SHE in the opinion of the investigator
- Intellectual disability or any Neurocognitive or Neurodevelopmental disorder that would prevent participants from following study procedures
- Any condition that the investigator believes would make participation in the study not in the best interest of the participant or would preclude successful completion of study activities
Sites / Locations
- University of California, San Francisco
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Digital CBT-I
Sleep hygiene education
Arm Description
Digitally-delivered CBT for insomnia accessed via web and/or mobile app
This group will receive access to sleep hygiene education delivered via digital written materials
Outcomes
Primary Outcome Measures
Change in the Insomnia Severity Index (ISI)
Validated questionnaire; a 7-item scale with total scores between 0 and 28 where higher scores indicate greater severity
Change in sleep onset latency (SOL)
Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days
Change in wake after sleep onset (WASO)
Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days
Secondary Outcome Measures
Insomnia Disorder remission (score <8) and response (change ≥6) on the ISI
Validated questionnaire; a 7-item scale with total scores between 0 and 28 where higher scores indicate greater severity
Insomnia disorder remission based on the SCID Insomnia Module
structured interview to assess for Insomnia Disorder
Change in sleep diary parameters: percent sleep efficiency (SE), total sleep time (TST), total time in bed (TTIB), and total wake time (TWT)
Each measured in minutes by daily sleep diaries (based on the Consensus Sleep Diary)
Change in the Sleep Condition Indicator (SCI-8)
Validated questionnaire; an 8-item scale with total scores between 0 and 32 where higher scores indicate better sleep
Change in the Generalized Anxiety Disorder Questionnaire (GAD-7)
Validated questionnaire; a 7-item scale with total scores between 0 and 21 where higher scores indicate greater severity
Change in the Patient Health Questionnaire (PHQ-8)
Validated questionnaire; an 8-item scale with total scores between 0 and 24 where higher scores indicate greater severity
Change in the Insomnia Severity Index (ISI)
Validated questionnaire; a 7-item scale with total scores between 0 and 28 where higher scores indicate greater severity
Change in sleep onset latency (SOL)
Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days
Change in wake after sleep onset (WASO)
Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days
Full Information
NCT ID
NCT05541055
First Posted
September 7, 2022
Last Updated
August 25, 2023
Sponsor
Big Health Inc.
Collaborators
University of California, San Francisco
1. Study Identification
Unique Protocol Identification Number
NCT05541055
Brief Title
Digital CBT-I for Insomnia Disorder
Acronym
CrEDIT
Official Title
Clinical Effectiveness of Digital CBT-I for the Treatment of Insomnia Disorder: A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
August 2023
Overall Recruitment Status
Completed
Study Start Date
November 8, 2022 (Actual)
Primary Completion Date
May 15, 2023 (Actual)
Study Completion Date
August 24, 2023 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Big Health Inc.
Collaborators
University of California, San Francisco
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This study will examine the effectiveness of digital CBT-I versus sleep hygiene education in reducing insomnia severity, sleep onset latency, and wake after sleep onset in those with insomnia disorder.
Detailed Description
This study aims to examine the effectiveness of a fully-automated web and app-based digital CBT-I for insomnia compared to sleep hygiene education (SHE) in individuals with a diagnosis of insomnia disorder. Primary outcomes of interest include changes in insomnia severity, sleep onset latency, and wake after sleep onset throughout the course of the study.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Insomnia Disorder
Keywords
Insomnia, digital CBT, CBT-I
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
InvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
336 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Digital CBT-I
Arm Type
Experimental
Arm Description
Digitally-delivered CBT for insomnia accessed via web and/or mobile app
Arm Title
Sleep hygiene education
Arm Type
Active Comparator
Arm Description
This group will receive access to sleep hygiene education delivered via digital written materials
Intervention Type
Device
Intervention Name(s)
digital CBT-I
Intervention Description
A fully-automated and personalized digital intervention based on principles from cognitive behavioral therapy for insomnia.
Intervention Type
Other
Intervention Name(s)
Sleep hygiene education
Intervention Description
Participants will be provided with sleep hygiene advice which will be delivered digitally all at once upon allocation to the SHE arm. Participants will be able to revisit content during the trial as they wish.
Primary Outcome Measure Information:
Title
Change in the Insomnia Severity Index (ISI)
Description
Validated questionnaire; a 7-item scale with total scores between 0 and 28 where higher scores indicate greater severity
Time Frame
From baseline to 10 weeks post-randomization
Title
Change in sleep onset latency (SOL)
Description
Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days
Time Frame
From baseline to 10 weeks post-randomization
Title
Change in wake after sleep onset (WASO)
Description
Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days
Time Frame
From baseline to 10 weeks post-randomization
Secondary Outcome Measure Information:
Title
Insomnia Disorder remission (score <8) and response (change ≥6) on the ISI
Description
Validated questionnaire; a 7-item scale with total scores between 0 and 28 where higher scores indicate greater severity
Time Frame
10, 16, and 24 weeks post-randomization
Title
Insomnia disorder remission based on the SCID Insomnia Module
Description
structured interview to assess for Insomnia Disorder
Time Frame
Week -1 compared to weeks 10, 16, and 24 post-randomization
Title
Change in sleep diary parameters: percent sleep efficiency (SE), total sleep time (TST), total time in bed (TTIB), and total wake time (TWT)
Description
Each measured in minutes by daily sleep diaries (based on the Consensus Sleep Diary)
Time Frame
From lead-in period to 10, 16, and 24 weeks post-randomization
Title
Change in the Sleep Condition Indicator (SCI-8)
Description
Validated questionnaire; an 8-item scale with total scores between 0 and 32 where higher scores indicate better sleep
Time Frame
From baseline to weeks 10, 16, and 24 post-randomization
Title
Change in the Generalized Anxiety Disorder Questionnaire (GAD-7)
Description
Validated questionnaire; a 7-item scale with total scores between 0 and 21 where higher scores indicate greater severity
Time Frame
From baseline to weeks 10, 16, and 24 post-randomization
Title
Change in the Patient Health Questionnaire (PHQ-8)
Description
Validated questionnaire; an 8-item scale with total scores between 0 and 24 where higher scores indicate greater severity
Time Frame
From baseline to weeks 10, 16 and 24 post-randomization
Title
Change in the Insomnia Severity Index (ISI)
Description
Validated questionnaire; a 7-item scale with total scores between 0 and 28 where higher scores indicate greater severity
Time Frame
From baseline to weeks 16 and 24 post-randomization
Title
Change in sleep onset latency (SOL)
Description
Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days
Time Frame
From baseline to weeks 16 and 24 post-randomization
Title
Change in wake after sleep onset (WASO)
Description
Measured by daily sleep diaries (based on the Consensus Sleep Diary) averaged across 10 days
Time Frame
From baseline to weeks 16 and 24 post-randomization
10. Eligibility
Sex
All
Minimum Age & Unit of Time
22 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Age ≥22 years old
Insomnia Disorder diagnosis
Score ≤16 on the 8-item Sleep Condition Indicator
> 30 minutes sleep onset latency (SOL); and/or > 30 minutes wake after sleep onset (WASO)
Current resident of the USA
Oral and written fluency in English
Participant is able and willing to comply with protocol requirements, has been informed of the nature of the study, and has signed the IRB-approved informed consent form
Exclusion Criteria:
Must not be currently receiving or be expecting to start CBT for insomnia during study participation, or have previously received CBT for insomnia in the past 12-months (self-report)
If on psychoactive medication, including sleep medication, this must be stable for at least 5 half lives
Past or present psychosis, schizophrenia, bipolar disorder, assessed by self-report and/or seizure disorder
Occupation that requires alertness / caution to avoid accidents, for example long-haul driving, long distance bus driver, heavy machinery operator, air traffic controller
Hearing or vision impairment that prevents effective use of the audio-visual content of digital CBT-I or SHE in the opinion of the investigator
Intellectual disability or any Neurocognitive or Neurodevelopmental disorder that would prevent participants from following study procedures
Any condition that the investigator believes would make participation in the study not in the best interest of the participant or would preclude successful completion of study activities
Facility Information:
Facility Name
University of California, San Francisco
City
San Francisco
State/Province
California
ZIP/Postal Code
94143
Country
United States
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Digital CBT-I for Insomnia Disorder
We'll reach out to this number within 24 hrs